Skip to main content

Edwards Lifesciences Corp

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

EW$104.71+2.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Form 10-K Annual Report—2024

PART I
Item 1.Business2
Item 1A.Risk Factors12
Item 1B.Unresolved Staff Comments21
Item 1C.Cybersecurity21
Item 2.Properties22
Item 3.Legal Proceedings22
Item 4.Mine Safety Disclosures23
PART II
Item 5.Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities24
Item 6.[Reserved]25
Item 7.Management's Discussion and Analysis of Financial Condition and Results of Operations25
Item 7A.Quantitative and Qualitative Disclosures About Market Risk39
Item 8.Financial Statements and Supplementary Data41
Item 9.Changes in and Disagreements With Accountants on Accounting and Financial Disclosure105
Item 9A.Controls and Procedures105
Item 9B.Other Information105
Item 9C.Disclosure Regarding Foreign Jurisdictions That Prevent Inspections105
PART III
Item 10.Directors, Executive Officers and Corporate Governance106
Item 11.Executive Compensation106
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters106
Item 13.Certain Relationships and Related Transactions, and Director Independence106
Item 14.Principal Accounting Fees and Services106
PART IV
Item 15.Exhibits and Financial Statement Schedules107
Signatures109
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.